ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Efficacy of Subcutaneous Semaglutide Dose Escalation in Reducing Insulin in Patients With Type 2 Diabetes.
Alisha Halver et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.